Important Recall: 60,000 Doxazosin Blood Pressure Tablets Recall

Important Recall: 60,000 Doxazosin Blood Pressure Tablets Recall

Important Recall: 60,000 Doxazosin Blood Pressure Tablets Recall

Quick read below — save or share if useful.

**60,000 Blood Pressure Tablets Recalled Nationwide** In a recent announcement by the U.S. Food and Drug Administration (FDA), it was revealed that 60,000 doxazosin tablets have been recalled due to an issue with the tablets being imprinted with the wrong ID. The recall, which was initiated on January 21, has raised concerns among consumers who rely on this particular blood pressure medication for their health management. **Understanding the Recall** According to the FDA report, the reason for the recall is the incorrect imprinting of the tablets, which violates the requirement for unique identification of solid oral dosage drugs. The details of the affected tablets include the following: - Doxazosin Tablets, USP - 1000-count tablets per bottle - 4 milligram (mg) dosage - NDC (National Drug Code) 29300-353-10 - Lot # GDSH25006 - Expiry Date: 08/2027 The recall was classified as a Class III, which means that the use of the violative product is not likely to cause adverse health consequences. However, it is crucial for consumers to be aware of the issue and take appropriate action. **The Impact of Doxazosin** Doxazosin is a medication commonly used to treat high blood pressure and benign enlargement of the prostate. By relaxing the blood vessels and prostate muscles, this drug helps manage these conditions and improve overall health. Prostate enlargement is a common issue among men over 50, with the prevalence increasing with age. **Stay Informed for Your Health** It is essential for consumers to stay informed about medication recalls and ensure that they are taking the appropriate steps to manage their health effectively. By subscribing to reputable health newsletters and following reliable sources on social media, you can stay updated on the latest news and information related to your well-being. In conclusion, the recall of 60,000 blood pressure tablets nationwide serves as a reminder of the importance of medication safety and regulation. As consumers, it is our responsibility to stay informed, take action when necessary, and prioritize our health above all else. Remember, your health is your most valuable asset, so take care of it and stay informed. Stay safe and be proactive about your well-being.

Follow & Connect
Explore My Other Blogs

Enjoyed this post? Share it or explore more across my blogs and channels.

Comments